# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-21-077143
Filing Date
2021-06-04
Accepted
2021-06-04 17:11:43
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE REVISED PROXY | tm212548-4_defr14a.htm | DEFR14A | 866833
2 | GRAPHIC | lg_avadelpharm-4c.jpg | GRAPHIC | 46177
3 | GRAPHIC | tm212548d2-prxy_avadel1bw.jpg | GRAPHIC | 248278
4 | GRAPHIC | tm212548d2-prxy_avadel24c.jpg | GRAPHIC | 341238
5 | GRAPHIC | tm212548d2-prxy_avadel2bw.jpg | GRAPHIC | 217583
6 | GRAPHIC | tm212548d4-proxy_01page4c.jpg | GRAPHIC | 1433580
| Complete submission text file | 0001104659-21-077143.txt |  | 4001921

Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 21997328
SIC: 2834 Pharmaceutical Preparations